Related Experiment Video
Updated: Mar 21, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Antifungal susceptibility of 175 Aspergillus isolates from various clinical and environmental sources
Raquel Sabino1, Elisabete Carolino2, Cristina Veríssimo1
1National Institute of Health Dr. Ricardo Jorge - URSZ- Infectious Diseases Department, Lisbon, Portugal.
Abstract:
Some environmental Aspergillus spp. isolates have been described as resistant to antifungals, potentially causing an emerging medical problem. In the present work, the antifungal susceptibility profile of 41 clinical and 134 environmental isolates of Aspergillus was determined using the CLSI microdilution method. The aim of this study was to compare environmental and clinical isolates with respect to their susceptibility, and assess the potential implications for therapy of isolates encountered in different environments. To our knowledge, this is the first report comparing antifungal susceptibility profiles of Aspergillus collected from different environmental sources (poultries, swineries, beach sand, and hospital environment). Significant differences were found in the distribution of the different species sections for the different sources. Significant differences were also found in the susceptibility profile of the different Aspergillus sections recovered from the various sources. Clear differences were found between the susceptibility of clinical and environmental isolates for caspofungin, amphotericin B and posaconazole, with clinical isolates showing overall greater susceptibility, except for caspofungin. In comparison to clinical isolates, hospital environmental isolates showed significantly less susceptibility to amphotericin B and posaconazole. These data indicate that species section identity and the site from which the isolate was recovered influence the antifungal susceptibility profile, which may affect initial antifungal choices.
Insights
Environmental and clinical Aspergillus isolates show varying antifungal resistance. Hospital environmental isolates are less susceptible to key antifungals like amphotericin B, impacting treatment choices.
Area of Science:
- Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Environmental Aspergillus species can exhibit antifungal resistance, posing a potential public health concern.
- Understanding the susceptibility profiles of clinical and environmental Aspergillus isolates is crucial for effective antifungal therapy.
Purpose of the Study:
- To compare the antifungal susceptibility profiles of clinical and environmental Aspergillus isolates.
- To assess the implications of environmental source on antifungal resistance patterns.
- To investigate Aspergillus isolates from diverse environmental origins (poultries, swineries, beach sand, hospital settings).
Main Methods:
- Antifungal susceptibility testing was performed on 41 clinical and 134 environmental Aspergillus isolates.
- The Clinical and Laboratory Standards Institute (CLSI) microdilution method was employed.
- Isolates were sourced from various clinical and environmental locations, including hospital environments.
Main Results:
- Significant differences were observed in species distribution and antifungal susceptibility profiles across different environmental sources.
- Clinical isolates generally showed greater susceptibility to caspofungin, amphotericin B, and posaconazole compared to environmental isolates, with an exception for caspofungin.
- Hospital environmental isolates exhibited significantly lower susceptibility to amphotericin B and posaconazole than clinical isolates.
Conclusions:
- The species section of Aspergillus and its recovery site significantly influence antifungal susceptibility.
- Antifungal resistance patterns in environmental Aspergillus isolates, particularly from hospital settings, differ from clinical isolates.
- These findings highlight the need to consider isolate source when making initial antifungal treatment decisions.
Related Concept Videos
Antifungal Agents
Fungal Phylum Microsporidia

